News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

PressDigest

Valeant seeks help of top shareholders for sweetened Salix bid

Valeant Pharmaceuticals is understood to be considering issuing new preferred equity to some of its biggest shareholders to finance a sweetened, all-cash bid for Salix Pharmaceuticals.

WSJ Logo